OnSite® Dengue IgG/IgM Combo Rapid Test
The OnSite® Dengue IgG/IgM Combo Rapid Test is a lateral flow immunoassay designed for the simultaneous detection and differentiation of IgG and IgM antibodies against all four dengue virus serotypes (DEN1, DEN2, DEN3, DEN4). This noninvasive, point-of-care diagnostic test allows healthcare professionals to identify current or past dengue infections quickly and accurately, supporting timely treatment and outbreak management.
Key Features & Benefits
Detects All Four Dengue Serotypes: Provides comprehensive antibody detection for DEN1, DEN2, DEN3, and DEN4
Rapid Results: Test results are available within 15 minutes, enabling quick clinical decisions
User-Friendly: Can be performed by minimally trained personnel without laboratory equipment
Versatile Sample Compatibility: Works with human serum, plasma, or whole blood
High Accuracy: Utilizes recombinant chimeric dengue virus licensed from the US CDC for reliable detection
Portable & Convenient: Ideal for clinics, hospitals, community health programs, and field testing
Ideal Uses
Clinical and hospital settings for routine dengue antibody testing
Community health and outbreak response programs
Point-of-care diagnostics in remote or resource-limited areas
Travel medicine clinics for screening patients returning from dengue-endemic regions
Epidemiological and research studies requiring rapid IgG/IgM detection
Technical Specifications
| Specification | Details |
|---|---|
| Test Method | Lateral flow immunoassay (rapid antibody test) |
| Sample Type | Serum, plasma, or whole blood |
| Sample Volume | 10–20 µL |
| Detection | IgG and IgM antibodies to dengue virus (DEN1–4) |
| Test Time | 15 minutes |
| Storage Conditions | 2–30°C, dry environment |
| Shelf Life | 24 months from manufacture |
| Display | Visual line for qualitative interpretation |
| Intended Use | Professional point-of-care dengue diagnosis |
| Regulatory Compliance | CE-marked |
